Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Phac2g04691 | ATGGAGATGGATCCTCCACCCAAGAGCTGGAGCATCCATACCCGATCCGAGATCATCGCCAAGTACGAGGTCATGGAGCGGGTCGGGTCAGGAGCTTACGCCGACGTCTACCGCGGCCGTCGCCTCTCCGATGGCCTCACCGTCGCCCTCAAAGAAATCCACGACTACCAGTCCGCGTTCCGAGAAATCGATGCGTTAGAGCTCCTCCAGGGATTCCCAAACGTCATCGTTTTGCACGAGTACTTCTGGCGCGAGGACGAAGACGCCGTCCTCGTCCTCGAGTTCCTCAGGACAGACTTGGCAACCGTCATCGCTGACGCCGCCAAGGCCAACCAGCCCCTCCCCGCCGGCCAGCTCAAGCGCTGGATGATCCAGATTCTCTCTGGCGTCGACGCCTGCCACCGCAACATGGTCCTCCATCGTGATTTGAAGCCCTCGAATCTCTTAATTTCCGAAAACGGCCTCCTCAAGATCGCCGATTTTGGACAGGCAAGAATTCTCACGGAGCCTGGATTTGATGCTTCTAATAATCATGAAGAATATTCTAGAGACATTGATAATAAGGATACTAGTACTAATACTCACGATGGAAATGCAACATGCACCACAAGTGACATTGACAGGGAAGATGAAGAGAAAGAACTTGGTTGTTTCACTTCATGTGTTGGGACTCGTTGGTTTAGGGCTCCTGAGTTGCTTTATGGATCCAGAGACTATGGTTTGGAGGTTGATTTGTGGTCCTTGGGATGTATATTTGCGGAGCTATTAACTCTGCGGCCTTTGTTTCCTGGAGCTGCTGATATTGACCAGATCAGTAGAATCATTGGAGTTTTGGGTAACCTCGATGAGAGTATTTGGGTTGGTTGTTCTAAACTTCCTGATTATGGGATAATTTCCTTTAGCAAGGTGGAAAACCCTTCTGGTATTGAAGCCTGTTTACCTAATAGGTCCCCTGATGAAGTGGCTCTGGTGAAAAGACTGGTTTGTTATGATCCTGCTAAGAGGGCTACGGCAATGGAGTTGATTCATGACAAGTACTTTAATGAAGAGCCTCTTCCTGTGCCGGTTTCTGAGCTGCCAGTTCCTCTTAACAGAAAAGGGCAAGATGAGGATTCCCCTGGTGGGTGGGGTGATTTAGATGAAATGGAATCTGATTCTGATTTTGATGAGTTTGGCCCTCTCAATATCACAAGAACTGGTACCGGTTTCTCCATACAGTTTCCTTGA | 1227 | 0.4931 | MEMDPPPKSWSIHTRSEIIAKYEVMERVGSGAYADVYRGRRLSDGLTVALKEIHDYQSAFREIDALELLQGFPNVIVLHEYFWREDEDAVLVLEFLRTDLATVIADAAKANQPLPAGQLKRWMIQILSGVDACHRNMVLHRDLKPSNLLISENGLLKIADFGQARILTEPGFDASNNHEEYSRDIDNKDTSTNTHDGNATCTTSDIDREDEEKELGCFTSCVGTRWFRAPELLYGSRDYGLEVDLWSLGCIFAELLTLRPLFPGAADIDQISRIIGVLGNLDESIWVGCSKLPDYGIISFSKVENPSGIEACLPNRSPDEVALVKRLVCYDPAKRATAMELIHDKYFNEEPLPVPVSELPVPLNRKGQDEDSPGGWGDLDEMESDSDFDEFGPLNITRTGTGFSIQFP* | 409 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Phac2g04691 | 408 | MobiDBLite | consensus disorder prediction | 176 | 191 | - | - | |
Phac2g04691 | 408 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 138 | 150 | IPR008271 | GO:0004672|GO:0006468 | |
Phac2g04691 | 408 | MobiDBLite | consensus disorder prediction | 172 | 205 | - | - | |
Phac2g04691 | 408 | Gene3D | Phosphorylase Kinase; domain 1 | 13 | 108 | - | - | |
Phac2g04691 | 408 | SUPERFAMILY | Protein kinase-like (PK-like) | 15 | 353 | IPR011009 | - | |
Phac2g04691 | 408 | SMART | serkin_6 | 22 | 347 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Phac2g04691 | 408 | ProSitePatterns | Protein kinases ATP-binding region signature. | 28 | 51 | IPR017441 | GO:0005524 | |
Phac2g04691 | 408 | ProSiteProfiles | Protein kinase domain profile. | 22 | 347 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Phac2g04691 | 408 | PANTHER | CELL DIVISION PROTEIN KINASE | 21 | 353 | - | - | |
Phac2g04691 | 408 | MobiDBLite | consensus disorder prediction | 374 | 388 | - | - | |
Phac2g04691 | 408 | Pfam | Protein kinase domain | 22 | 347 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Phac2g04691 | 408 | Gene3D | Transferase(Phosphotransferase) domain 1 | 109 | 350 | - | - | |
Phac2g04691 | 408 | MobiDBLite | consensus disorder prediction | 358 | 408 | - | - | |
Phac2g04691 | 408 | FunFam | Cyclin-dependent kinase F-1 | 13 | 107 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Phac2g04691 | Phac-Chr2 | 44011861 | 44016644 | Tandem |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Phac2g04691 | 6 | 408 | Core Cell Cycle Gene Families | AT4G28980 | 57.474 | 0.0 | 533 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | CMGC_CDK-CCRK | Phac2g04691 | Pkinase | 7.7e-54 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Phac2g04691 | - | - | vum:124837370 | 778.089 |